Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

2,570 studies match

clinicaltrialsPublishedShowing 501–550 of 2,570 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07084896	Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM	active not recruiting	Phase 1 / Phase 2	106	GlaxoSmithKlineINDUSTRY	13	May 6, 2026	clinicaltrials
NCT05064358	Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma(DREAMM 14)	completed	Phase 2	177	GlaxoSmithKlineINDUSTRY	18	May 5, 2026